These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

901 related articles for article (PubMed ID: 15755876)

  • 1. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
    Hu J; Colburn NH
    Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappaB inhibits transcription of the H(+)-K(+)-ATPase alpha(2)-subunit gene: role of histone deacetylases.
    Zhang W; Kone BC
    Am J Physiol Renal Physiol; 2002 Nov; 283(5):F904-11. PubMed ID: 12372765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells.
    Katsura T; Iwai S; Ota Y; Shimizu H; Ikuta K; Yura Y
    Cancer Gene Ther; 2009 Mar; 16(3):237-45. PubMed ID: 18949013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional silencing of the death gene BNIP3 by cooperative action of NF-kappaB and histone deacetylase 1 in ventricular myocytes.
    Shaw J; Zhang T; Rzeszutek M; Yurkova N; Baetz D; Davie JR; Kirshenbaum LA
    Circ Res; 2006 Dec; 99(12):1347-54. PubMed ID: 17082476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation.
    Choi KC; Jung MG; Lee YH; Yoon JC; Kwon SH; Kang HB; Kim MJ; Cha JH; Kim YJ; Jun WJ; Lee JM; Yoon HG
    Cancer Res; 2009 Jan; 69(2):583-92. PubMed ID: 19147572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [NF-kappaB modulates activation of the BMP-2 gene by trichostatin A].
    Li X; Bai XZ
    Mol Biol (Mosk); 2008; 42(6):990-6. PubMed ID: 19140318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
    Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation.
    Mulholland NM; Soeth E; Smith CL
    Oncogene; 2003 Jul; 22(31):4807-18. PubMed ID: 12894222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.
    Aggarwal S; Ichikawa H; Takada Y; Sandur SK; Shishodia S; Aggarwal BB
    Mol Pharmacol; 2006 Jan; 69(1):195-206. PubMed ID: 16219905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
    Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
    Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-8 expression is regulated by histone deacetylases through the nuclear factor-kappaB pathway in breast cancer.
    Chavey C; Mühlbauer M; Bossard C; Freund A; Durand S; Jorgensen C; Jobin C; Lazennec G
    Mol Pharmacol; 2008 Nov; 74(5):1359-66. PubMed ID: 18669446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p52-Bcl3 complex promotes cyclin D1 expression in BEAS-2B cells in response to low concentration arsenite.
    Wang F; Shi Y; Yadav S; Wang H
    Toxicology; 2010 Jun; 273(1-3):12-8. PubMed ID: 20420878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of complement component (C3 and factor B) biosynthesis by a histone deacetylase inhibitor in human intestinal epithelial cells.
    Andoh A; Fujiyama Y; Shimada M; Bamba T
    Int J Mol Med; 2000 Jul; 6(1):51-4. PubMed ID: 10851266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
    Lu X; Farmer P; Rubin J; Nanes MS
    J Cell Biochem; 2004 Jul; 92(4):833-48. PubMed ID: 15211579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation.
    Imre G; Gekeler V; Leja A; Beckers T; Boehm M
    Cancer Res; 2006 May; 66(10):5409-18. PubMed ID: 16707469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1.
    Shetty S; Graham BA; Brown JG; Hu X; Vegh-Yarema N; Harding G; Paul JT; Gibson SB
    Mol Cell Biol; 2005 Jul; 25(13):5404-16. PubMed ID: 15964798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RelA/p65 subunit of NF-kappaB specifically regulates cyclin D1 protein stability: implications for cell cycle withdrawal and skeletal myogenesis.
    Dahlman JM; Wang J; Bakkar N; Guttridge DC
    J Cell Biochem; 2009 Jan; 106(1):42-51. PubMed ID: 19016262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella-zoster virus modulates NF-kappaB recruitment on selected cellular promoters.
    El Mjiyad N; Bontems S; Gloire G; Horion J; Vandevenne P; Dejardin E; Piette J; Sadzot-Delvaux C
    J Virol; 2007 Dec; 81(23):13092-104. PubMed ID: 17855547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.